Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4737 is a member of the non-coding RNA family known as microRNAs, which are short RNAs (20–24 nucleotides) involved in the post-transcriptional regulation of gene expression in multicellular organisms. MicroRNAs such as MIR4737 are transcribed as part of primary transcripts and processed into mature miRNA, which incorporate into the RNA-induced silencing complex (RISC). They regulate target mRNAs through imperfect base pairing, generally leading to translational inhibition or destabilization of the target mRNA. While microRNAs play important roles in developmental regulation, cell proliferation, differentiation, and buffering gene expression against environmental perturbations, there is no specific functional or disease-related information available for microRNA 4737 at present[1][2][3][4][5].
Inhibition of translation and degradation of target mRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4737 (MIR4737).